Beximco Pharmaceuticals Limited Sponsored GDR RegS (R2WA) Stock Forecast & Price Target
R2WA Analyst Ratings
There are no analyst ratings in the last 3 months.
R2WA Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
No analyst ratings match these filters.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
R2WA Financial Forecast
ConsensusEUR 0.04
R2WA Earnings Forecast
Next quarter’s earnings estimate for R2WA is EUR 0.04 with a range of ― to ―. The previous quarter’s EPS was EUR 0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ConsensusEUR 99M
R2WA Sales Forecast
Next quarter’s sales forecast for R2WA is EUR 99.01M with a range of ― to ―. The previous quarter’s sales results were EUR 99.01M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
R2WA Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Beximco Pharmaceuticals Limited Sponsored GDR RegS?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Beximco Pharmaceuticals Limited Sponsored GDR RegS?
To buy shares of DE:R2WA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
